Athena Diagnostics now offers content specific to our Canadian customers.
Please let us know where you are from.
I am from
From time to time Athena Diagnostics sends out important service related announcements including new test launches and updates via E-Mail. Please take a moment to provide an E-Mail address to which Athena may send these important announcements.
Athena Diagnostics will not sell or distribute your E-Mail address to any other company or organization. It will be used for the sole purpose of sending information on new tests and updates to existing tests. You may unsubscribe from the E-Mail list at any time. For questions regarding E-Mails you receive from Athena Diagnostics please call 800-394-4493, option 2.
You will now receive occasional updates from Athena via e-mail. Thank you!
Enter a symptom, disease type, test name or code.
Select a disorder category from the list provided.
Access forms, resources, shipping materials and educational info.
Next Generation Sequencing Testing for Epilepsy Available April 2, 2014
Athena Diagnostics is pleased to announce the availability of next-generation sequencing for epilepsy, starting April 2, 2014. Epilepsy is one of the most common serious neurological diseases, characterized by multiple unprovoked seizures (surges of electrical activity in the brain that disrupt function). Read More >
Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders
Tests to be unveiled at the American Academy of Neurology | Annual Meeting in San Diego, March 16-23, 2013 Read More >